Description
CurcumaSorb provides the patented curcumin-phosphatidylcholine
complex Meriva® for enhanced absorption and bioavailability.
The proprietary phytosome technology combines curcumin
and phosphatidylcholine at a 1:2 ratio promoting resistance
to degradation in the digestive tract and efficient absorption
across membranes. This produces significantly higher peak
plasma concentrations and larger area under concentration-time
curves (AUC). In a single-dose pharmacokinetic animal study,
plasma curcumin levels were 20-fold greater with Meriva® than
standard curcumin. A preliminary human pharmacokinetic study
demonstrated elevations in plasma curcumin from 450 mg Meriva®
were similar to values obtained from 4,000 mg of a standard
curcumin extract.*
